Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 19

1.

Minimal deviation melanoma.

Podnos YD, Jimenez JC, Zainabadi K, Jakowatz JG, Barr RJ.

Cancer Treat Rev. 2002 Oct;28(5):219-21. Review.

PMID:
12435369
2.

Minimal deviation melanoma. Borderline and intermediate melanocytic neoplasia.

Reed RJ.

Clin Lab Med. 2000 Dec;20(4):745-58. Review.

PMID:
11221513
3.

Radioguided sentinel lymph node biopsy in patients with malignant cutaneous melanoma: the nuclear medicine contribution.

Mariani G, Erba P, Manca G, Villa G, Gipponi M, Boni G, Buffoni F, Suriano S, Castagnola F, Bartolomei M, Strauss HW.

J Surg Oncol. 2004 Mar;85(3):141-51. Review.

PMID:
14991886
4.

Sentinel lymph node biopsy for melanoma: indications and rationale.

Phan GQ, Messina JL, Sondak VK, Zager JS.

Cancer Control. 2009 Jul;16(3):234-9. Review.

5.

Sentinel lymph node biopsy in patients with Stage I/II melanoma: Clinical experience and literature review.

Gipponi M, Di Somma C, Peressini A, Solari N, Gliori S, Nicolo G, Schenone F, Queirolo P, Sertoli MR, Cafiero F.

J Surg Oncol. 2004 Mar;85(3):133-40. Review.

PMID:
14991885
6.

Pathology of melanocytic lesions: new, controversial, and clinically important issues.

Scolyer RA, Thompson JF, Stretch JR, Sharma R, McCarthy SW.

J Surg Oncol. 2004 Jul 1;86(4):200-11. Review.

PMID:
15221927
7.

Pediatric melanoma: a review.

Mills O, Messina JL.

Cancer Control. 2009 Jul;16(3):225-33. Review.

8.

Current status of sentinel lymph node mapping and biopsy: facts and controversies.

Jakub JW, Pendas S, Reintgen DS.

Oncologist. 2003;8(1):59-68. Review.

9.

Sentinel node biopsy for thin melanomas: which patients should be considered?

Puleo CA, Messina JL, Riker AI, Glass LF, Nelson C, Cruse CW, Johnson TM, Sondak VK.

Cancer Control. 2005 Oct;12(4):230-5. Review.

10.

Melanoma risk in congenital melanocytic naevi: a systematic review.

Krengel S, Hauschild A, Schäfer T.

Br J Dermatol. 2006 Jul;155(1):1-8. Review.

PMID:
16792745
11.

Role of sentinel lymph node biopsy in patients with thin melanoma.

Andtbacka RH, Gershenwald JE.

J Natl Compr Canc Netw. 2009 Mar;7(3):308-17. Review.

PMID:
19401063
12.

Should all melanoma patients undergo sentinel lymph node biopsy?

Ra JH, McMasters KM, Spitz FR.

Curr Opin Oncol. 2006 Mar;18(2):185-8. Review.

PMID:
16462189
13.

Cutaneous melanomas of the eyelid.

Boulos PR, Rubin PA.

Semin Ophthalmol. 2006 Jul-Sep;21(3):195-206. Review.

PMID:
16912018
14.

Clinical aspects of sentinel lymph node biopsy in melanoma.

Ariyan CE, Coit DG.

Semin Diagn Pathol. 2008 May;25(2):86-94. Review.

PMID:
18697711
15.
16.

[Experiences with the new American Joint Committee on Cancer (AJCC) classification of cutaneous melanoma].

Eigentler TK, Radny P, Kamin A, Weide B, Caroli UM, Garbe C.

J Dtsch Dermatol Ges. 2005 Aug;3(8):592-8. Review. German.

PMID:
16033477
17.

Lymphatic mapping and sentinel lymphadenectomy in primary cutaneous melanoma.

Scheri RP, Essner R.

Expert Rev Anticancer Ther. 2006 Jul;6(7):1105-10. Review.

PMID:
16831081
18.

[Biopsy of sentinel lymph node in melanoma is not yet the standard treatment].

Gallegos-Hernández JF, Nieweg OE, Tanis PJ, Valdés-Olmos RA, Kroon BB.

Gac Med Mex. 2003 Sep-Oct;139(5):449-52. Review. Spanish.

PMID:
14635563
19.

National trials involving lymphatic mapping for melanoma: the Multicenter Selective Lymphadenectomy Trial, the Sunbelt Melanoma Trial, and the Florida Melanoma Trial.

Reintgen D, Pendas S, Jakub J, Swor G, Giuliano R, Bauer J, Cassall R, Duhaime L, Alsarrai M, Shivers S.

Semin Oncol. 2004 Jun;31(3):363-73. Review.

PMID:
15190494
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk